Jake M. Najman, Scott Bell, Gail M. Williams, Alexandra M. Clavarino, James G. Scott, Tara R. McGee, Abdullah A. Mamun
January 17, 2023
Use of tobacco and cannabis is common and has been reported to predict lung function. Less is known about co-use of tobacco and cannabis and their impact on changes in lung function to early adulthood.
The study examines whether cigarette smoking or cannabis use and co-use are each associated with lung function in a population sample of young adults.
Study design and methods
Data are from a prospective cohort study of cigarette smoking, cannabis use and co-use at 21 and 30 years of age and lung function (FVC, FEV1, FEV1/FVC) measured at 30 years. Lung function results are transformed using Global Lung Function Formulae. Subjects are the children of pregnant women who were recruited into the cohort study over the period 1981–3. Respondents were administered a spirometry assessment at 21 and 30 years of age. These respondents completed a smoking and cannabis use questionnaire at 21- and 30-year follow-ups.
Cigarette smoking (with or without cannabis use) is associated with reduced airflow. There is no consistent association between cannabis use and measures of lung function. The co-use of tobacco and cannabis appears to entail no additional risk to lung function beyond the risks associated with tobacco use alone.
Persistent cigarette smoking is associated with reduced airflow even in young adults. Cannabis use does not appear to be related to lung function even after years of use.
Li, J., Jiang, W., Shan, W., Luo, A., Qu, G., Zhang, J., … & Xia, J. (2023). The synergistic anticancer effect of CBD and DOX in osteosarcoma. Clinical and Translational Oncology, 1-11.